The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration - Scorecard - MDSpire

The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

  • By

  • Aleksander Dominikowski

  • Zofia Rękoś

  • Michał Olejarz

  • Ewelina Szczepanek-Parulska

  • Remigiusz Domin

  • Marek RuchaŁa

  • June 18, 2026

  • 0 min

Share

Clinical Scorecard: The Evolving Role of Performance-Enhancing Peptides in Regulating the GH-IGF1 Pathway: Connecting Clinical Research to Patient Use

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target Population
Care SettingClarify the distinction between clinical practice and self-administration contexts.

Key Highlights

  • adverse_effects

Guideline-Based Recommendations

Diagnosis

    Management

    • E
    • x
    • p
    • a
    • n
    • d
    • o
    • n
    • m
    • a
    • n
    • a
    • g
    • e
    • m
    • e
    • n
    • t
    • s
    • t
    • r
    • a
    • t
    • e
    • g
    • i
    • e
    • s
    • f
    • o
    • r
    • c
    • l
    • i
    • n
    • i
    • c
    • i
    • a
    • n
    • s
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Clarify implications of self-administration on patient outcomes.

        Clinical Best Practices

        • educational_resources

        Related Resources & Content

        Original Source(s)

        The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration

        • by Aleksander Dominikowski, Zofia Rękoś, Michał Olejarz, Ewelina Szczepanek-Parulska, Remigiusz Domin, Marek RuchaŁa

        • June 18, 2026

        Related Content

        FDA Expands CAPVAXIVE Pediatric Use

        Phase 3 data showed noninferior immune responses vs pneumococcal 23-valent polysaccharide vaccine in pediatric patients at increased risk.

        Diagnostic value of tubular and glomerular biomarkers across different stages of kidney injury in patients with type 2 diabetic nephropathy

        Endometrial dysfunction in embryo implantation: from molecular mechanisms to clinical management